Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. - Test2 - elhamkhani - TriplyDB

Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells.

Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells.

http://www.wikidata.org/entity/Q30441613

about

Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance.Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease Dopamine Receptors and Neurodegeneration The Synergistic Roles of Cholecystokinin B and Dopamine D5 Receptors on the Regulation of Renal Sodium Excretion.Sorting nexin 5 and dopamine d1 receptor regulate the expression of the insulin receptor in human renal proximal tubule cells.Dopamine D3 receptor inhibits the ubiquitin-specific peptidase 48 to promote NHE3 degradation.Sorting nexin 1 loss results in D5 dopamine receptor dysfunction in human renal proximal tubule cells and hypertension in mice Diagnostic tools for hypertension and salt sensitivity testing.Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells.Rab4 and Rab11 coordinately regulate the recycling of angiotensin II type I receptor as demonstrated by fluorescence resonance energy transfer microscopy.Inhibition of renal caveolin-1 reduces natriuresis and produces hypertension in sodium-loaded rats.Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.Actin cytoskeleton-dependent Rab GTPase-regulated angiotensin type I receptor lysosomal degradation studied by fluorescence lifetime imaging microscopy Genetics of salt-sensitive hypertension.Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice.D1-like dopamine receptors downregulate Na+-K+-ATPase activity and increase cAMP production in the posterior gills of the blue crab Callinectes sapidus.Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II.Renal dopamine receptors, oxidative stress, and hypertension.Lack of renal dopamine D5 receptors promotes hypertension.Dopamine receptors: important antihypertensive counterbalance against hypertensive factors.Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1 Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra.Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury.Ubiquitination of G protein-coupled receptors: functional implications and drug discovery.Renal dopamine and angiotensin II receptor signaling in age-related hypertension.A single mutation in helix 8 enhances the angiotensin II type 1a receptor transport and signaling.Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra Minireview: ubiquitination-regulated G protein-coupled receptor signaling and trafficking Curcumin Exerts its Anti-hypertensive Effect by Down-regulating the AT1 Receptor in Vascular Smooth Muscle Cells.Insulin increases D5 dopamine receptor expression and function in renal proximal tubule cells from Wistar-Kyoto rats Upregulation of renal D5 dopamine receptor ameliorates the hypertension in D3 dopamine receptor-deficient mice.Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis.Dopamine D1 and D5 receptors differentially regulate oxidative stress through paraoxonase 2 in kidney cells.The role of the proteasome in heart disease Tissue Renin-Angiotensin systems: a unifying hypothesis of metabolic disease.Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system.Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.

P2860

Q24609255-C152A72F-D4F8-413E-92CA-56EC6B86AD36 Q26750370-1D3EA739-4B62-4C5B-AFB3-62EFAC970F28 Q26783348-7D76A8A5-DE4D-48D2-9D8E-A9479953EC1A Q30277777-7145F855-EE6E-44D3-BBAD-A553D0413A4F Q30300271-DFA6FD38-196C-40A7-A9CE-CF076D26E7C9 Q30407698-0E377016-413B-4A74-8DA8-DA02FC94095A Q30415400-A3C7DB53-19E9-43DE-A686-D14DACB008E2 Q30417367-A3E4D486-7BA4-4366-B525-ADFE00AA6905 Q30417907-DF330FF0-6EAB-4A27-89D4-5C48EAD67E69 Q30417931-90F2A720-AE46-4009-B2C2-2DFFE36B7F02 Q30427546-F544F35C-7A3D-472C-A0CA-041D0E9DE241 Q30429420-748BB69A-BC44-4279-AA5B-C06286251E0E Q30430343-7899D5E9-0FF6-4B1B-8FCC-A6574ED609DB Q33603268-9D186382-6596-4236-8930-E7F4F3523811 Q33737470-DD7761E0-7692-4A1D-B8D4-D38BC6E46B30 Q33876285-7EFBBD59-5818-402A-910B-04BD5A67C291 Q34201209-A6E6A6A2-C5AC-46D7-A6C5-6DD71995ABEF Q34305557-0530AF13-8976-457A-9ECE-AFB4D4938B72 Q34367267-BCE36703-B9A1-4B22-A0BF-E6F4027A8E04 Q34457253-148206F3-06C8-4C3D-9DDB-CADC06503608 Q34493275-441FEE93-0322-4A2E-82F1-498C9B766BC1 Q35572452-48A32436-FDA3-423B-8132-7AFF3411C61E Q35611392-478F917B-04A9-4665-8BEE-754BAFB27151 Q35806742-F25EDF39-F9DC-4A16-AEA6-FC57DD2202F8 Q35849467-20B935BE-97FF-4D43-AE69-AD47046CE628 Q36294416-6E7FEF3A-D203-445E-AC02-FCB966F5C5AE Q36527864-FDD289A8-A1C1-4AA3-A599-4F02AB93B627 Q36539181-F690895D-F742-4B28-9008-8EB6957D1AF0 Q36576487-EB38B664-B592-4DC6-839E-F47D3FF7C800 Q36632049-F01E1CEE-50E5-4B8A-89FE-0612AC6BDE19 Q36714881-47440749-8169-4978-A267-1563B6DB8B64 Q36870967-E800B949-542F-4999-B499-91D7245C92ED Q36994704-49F820A3-739F-4F01-9AC2-FCD207EE2C67 Q37193713-A54FC0BE-ABEF-451F-9C2B-17CF03D6BE87 Q37559630-D74DFD4E-ED1A-42B4-863B-6C2CBF690BB5 Q37603724-E9B0D270-1BF9-44D3-8C06-28D2C79FA1D0 Q37788836-3641EC5F-6F1F-4EAE-85E8-B08DF7938B0C Q38193086-4D2999A8-1F45-4BE3-B891-922B3ACF0463 Q38272996-690FE47F-1487-4BD9-9BBD-BF17540CB781 Q39198610-157D1B49-7784-4D7B-803E-7A719E2E94B1

P2860

Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells.

http://www.wikidata.org/entity/Q30441613

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Dopamine 5 receptor mediates A ...... thway in mice and human cells.

@ast

Dopamine 5 receptor mediates A ...... thway in mice and human cells.

@en

type

label

Dopamine 5 receptor mediates A ...... thway in mice and human cells.

@ast

Dopamine 5 receptor mediates A ...... thway in mice and human cells.

@en

prefLabel

Dopamine 5 receptor mediates A ...... thway in mice and human cells.

@ast

Dopamine 5 receptor mediates A ...... thway in mice and human cells.

@en

P1433

Q30441613-2325DD95-06E9-4684-88EE-6EEC29017C32

P1476

Q30441613-46CF83B8-0135-4397-B2CC-94E065A7CDDC

P2093

Q30441613-2C650E4D-AD56-42B9-815E-4702008D26A4

Q30441613-2EA13CC4-F8E5-475C-BE72-BA4C3EA7D182

Q30441613-72C12725-4A8E-4F19-923F-9E94B9DF58D8

Q30441613-775A0E47-AD72-44FB-808D-E9CB40DF0E37

Q30441613-7AF4BE8B-202A-4CCE-B89D-C9101C3AEBE7

Q30441613-8548B8DB-B208-4F7F-8CC3-3F1A5D2D5874

Q30441613-909E5CB9-9F94-4D08-86AB-DE0FE0337E9B

Q30441613-93858DF6-3848-4F35-BA49-DAEBFE7ECAF4

Q30441613-96FA6C5F-D318-457E-A551-0ECC7260903E

Q30441613-998A1693-8C3F-4F56-BC0D-E8BAF7683849

P2860

Q30441613-036221BE-F383-4B6E-9177-C0DA4414BF89

Q30441613-03A1D1D2-9C24-4FE5-A14D-01AB552AC802

Q30441613-03B930B4-FFB7-4BF8-8EB0-4428568897CD

Q30441613-05593EF7-F2A4-4C3F-8BA2-09197771D50E

Q30441613-05BCA39B-1DBC-4ADD-997E-468FE48FCA06

Q30441613-087218BB-8516-4D51-960E-1523F208882A

Q30441613-105006AB-C433-4A6E-ADF6-DC949B17CBDE

Q30441613-1AAECC82-85DF-4A7C-8385-A1BE80FAA7A8

Q30441613-1FA1952C-B140-4FAD-982E-641FEAD7982A

Q30441613-28E83F84-443B-438A-86A3-A495C69A3FB6

P304

Q30441613-1B66B11B-591D-4BBB-85BD-707784E544C8

P31

Q30441613-AFF5E018-052E-4C2D-9481-AF2E1173A6DC

P356

Q30441613-309704C1-BAF0-4811-B1ED-824072AEB17E

P407

Q30441613-F44DE792-7264-4DE4-8A50-429822A0389E

P433

Q30441613-EAAA154A-B6B0-4583-94A4-296CCB7C292F

P478

Q30441613-28A07D10-E040-479B-8907-360E670321DD

P50

Q30441613-0E82733C-7738-426F-9DCD-0884F60307B4

P577

Q30441613-894C6BDD-612D-4557-B74C-11FB794496D9

P698

Q30441613-56B7C067-F984-4213-927C-04DE4D2FCA6F

P921

Q30441613-2D9605BE-C0F6-4EBF-AA22-621BC3E081D6

Q30441613-e4f0fcd2-9ca0-4670-a6d9-7a379c7d85f2

P932

Q30441613-69462887-AA46-4AE7-A08B-48388DE257A5

P356

P1433

Journal of Clinical Investigation

P1476

Dopamine 5 receptor mediates A ...... athway in mice and human cells

@en

P2093

Ammasi Periasamy

http://www.w3.org/2001/XMLSchema#string

Annabelle Pascua

http://www.w3.org/2001/XMLSchema#string

Crisanto Escano

http://www.w3.org/2001/XMLSchema#string

David R Sibley

http://www.w3.org/2001/XMLSchema#string

Gaétan Guillemette

http://www.w3.org/2001/XMLSchema#string

Gilbert Eisner

http://www.w3.org/2001/XMLSchema#string

Hewang Li

http://www.w3.org/2001/XMLSchema#string

Ines Armando

http://www.w3.org/2001/XMLSchema#string

John E Jones

http://www.w3.org/2001/XMLSchema#string

John J Gildea

http://www.w3.org/2001/XMLSchema#string

P2860

N-linked glycosylation is required for plasma membrane localization of D5, but not D1, dopamine receptors in transfected mammalian cells

Differential dependence of the D1 and D5 dopamine receptors on the G protein gamma 7 subunit for activation of adenylylcyclase

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2

CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4

International union of pharmacology. XXIII. The angiotensin II receptors

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin

E3 ubiquitin ligase that recognizes sugar chains

Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive

Proteasome-independent functions of ubiquitin in endocytosis and signaling

P304

2180-2189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI33637

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Patrício Soares-da-Silva

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18464932

http://www.w3.org/2001/XMLSchema#string

P921

ubiquitin-proteasome system

P932

2373421

http://www.w3.org/2001/XMLSchema#string